The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Inverse agonism and neutral antagonism at cannabinoid CB1 receptors
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Self-citationVanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607
Leptin-regulated endocannabinoids are involved in maintaining food intake
Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Bátkai, S., Járai, Z., Fezza, F., Miura, G. I., Palmiter, R. D., Sugiura, T., et al. (2001) · Nature · doi:10.1038/35071088 · Cited by 1,559
Kreitzer, A. C., & Regehr, W. G. (2001) · Neuron · doi:10.1016/s0896-6273(01)00246-x · Cited by 875
Ohno-Shosaku, T., Maejima, T., & Kano, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00247-1 · Cited by 845
Cannabinoid receptors and pain
Pertwee, R. G. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00031-9 · Cited by 741
Self-citationModulation of transmitter release via presynaptic cannabinoid receptors
Schlicker, E., & Kathmann, M. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01805-8 · Cited by 671
Járai, Z., Wagner, J. A., Varga, K., Lake, K. D., Compton, D. R., Martin, B. R., Zimmer, A. M., Bonner, T. I., Buckley, N. E., Mezey, E., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14136 · Cited by 599
Ravinet Trillou, C., Delgorge, C., Menet, C., Arnone, M., & Soubrié, P. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802583 · Cited by 583
Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice
Ravinet Trillou, C., Arnone, M., Delgorge, C., Gonalons, N., Keane, P., Maffrand, J.-P., & Soubrié, P. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00545.2002 · Cited by 566
Cannabinoid receptors and their ligands
Pertwee, R. G., & Ross, R. A. (2002) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.2001.0341 · Cited by 561
Self-citationEvidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain
Breivogel, C. S., Griffin, G., Di Marzo, V., & Martin, B. R. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.1.155 · Cited by 541
Cannabinoids control spasticity and tremor in a multiple sclerosis model
Baker, D., Pryce, G., Croxford, J. L., Brown, P., Pertwee, R. G., Huffman, J. W., & Layward, L. (2000) · Nature · doi:10.1038/35003583 · Cited by 532
Self-citationThe two-state model of receptor activation
Leff, P. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)88989-0 · Cited by 488
Appetite suppression and weight loss after the cannabinoid antagonist SR 141716
Colombo, G., Agabio, R., Diaz, G., Lobina, C., Reali, R., & Gessa, G. L. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00322-1 · Cited by 487
Pain modulation by release of the endogenous cannabinoid anandamide
Walker, J. M., Huang, S. M., Strangman, N. M., Tsou, K., & Sañudo-Peña, M. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12198 · Cited by 485
The endocannabinoid system: a general view and latest additions
Petrocellis, L. D., Cascio, M. G., & Marzo, V. D. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705666 · Cited by 475
Bouaboula, M., Perrachon, S., Milligan, L., Canat, X., Rinaldi-Carmona, M., Portier, M., Barth, F., Calandra, B., Pecceu, F., Lupker, J., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22330 · Cited by 461
The endogenous cannabinoid system protects against colonic inflammation
Massa, F., Marsicano, G., Hermann, H., Cannich, A., Monory, K., Cravatt, B. F., Ferri, G.-L., Sibaev, A., Storr, M., & Lutz, B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19465 · Cited by 460
Hájos, N., Ledent, C., & Freund, T. F. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00287-1 · Cited by 419
Endocannabinoids control spasticity in a multiple sclerosis model
Baker, D., Pryce, G., Croxford, J. L., Brown, P., Pertwee, R. G., Makriyannis, A., Khanolkar, A., Layward, L., Fezza, F., Bisogno, T., et al. (2001) · The FASEB Journal · doi:10.1096/fj.00-0399fje · Cited by 378
Self-citationCompton, D. R., Aceto, M. D., Lowe, J., & Martin, B. R. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12911-x · Cited by 357
De Petrocellis, L., Bisogno, T., Maccarrone, M., Davis, J. B., Finazzi-Agrò, A., & Di Marzo, V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008555200 · Cited by 355
Cannabinoids and the gastrointestinal tract
PERTWEE, R. G. (2001) · Gut · doi:10.1136/gut.48.6.859 · Cited by 326
Self-citationHerzberg, U., Eliav, E., Bennett, G. J., & Kopin, I. J. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13308-5 · Cited by 307
Auclair, N., Otani, S., Soubrie, P., & Crepel, F. (2000) · Journal of Neurophysiology · doi:10.1152/jn.2000.83.6.3287 · Cited by 290
Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716
Terranova, J. P., Storme, J. J., Lafon, N., Pério, A., Rinaldi-Carmona, M., Le Fur, G., & Soubrié, P. (1996) · Psychopharmacology · doi:10.1007/bf02246352 · Cited by 283
SR141716A is an inverse agonist at the human cannabinoid CB1 receptor
Landsman, R. S., Burkey, T. H., Consroe, P., Roeske, W. R., & Yamamura, H. I. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01160-6 · Cited by 262
Huang, C., Lo, S., & Hsu, K. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0731e.x · Cited by 248
French, E. D. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00278-4 · Cited by 236
Felder, C. C., Joyce, K. E., Briley, E. M., Glass, M., Mackie, K. P., Fahey, K. J., Cullinan, G. J., Hunden, D. C., Johnson, D. W., Chaney, M. O., et al. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37189-7 · Cited by 233
Vickers, S. P., Webster, L. J., Wyatt, A., Dourish, C. T., & Kennett, G. A. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1384-8 · Cited by 207
Hájos, N., & Freund, T. F. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00157-0 · Cited by 202
Pan, X., Ikeda, S. R., & Lewis, D. L. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.6.1064 · Cited by 185
Tetrahydrocannabinol and endocannabinoids in feeding and appetite
Berry, E. M., & Mechoulam, R. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00257-7 · Cited by 184
Endocannabinoids as physiological regulators of colonic propulsion in mice
Pinto, L., Izzo, A. A., Mascolo, N., Capasso, F., Cascio, M. G., Bisogno, T., Di Marzo, V., Hospodar–Scott, K., & Brown, D. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.34242 · Cited by 180
Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors
MacLennan, S. J., Reynen, P. H., Kwan, J., & Bonhaus, D. W. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701915 · Cited by 175
Ross, R. A., Coutts, A. A., McFarlane, S. M., Anavi-Goffer, S., Irving, A. J., Pertwee, R. G., MacEwan, D. J., & Scott, R. H. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00135-0 · Cited by 172
Self-citationSR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats
Lichtman, A. H. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00615-4 · Cited by 171
Higgs, S., Williams, C. M., & Kirkham, T. C. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1263-3 · Cited by 165
An examination of the central sites of action of cannabinoid-induced antinociception in the rat
Martin, W. J., Patrick, S. L., Coffin, P. O., Tsou, K., & Walker, J. M. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00195-c · Cited by 165
McLaughlin, P. J., Winston, K., Swezey, L., Wisniecki, A., Aberman, J., Tardif, D. J., Betz, A. J., Ishiwari, K., Makriyannis, A., & Salamone, J. D. (2003) · Behavioural Pharmacology · doi:10.1097/00008877-200312000-00002 · Cited by 164
Further evidence for the presence of cannabinoid CB1 receptors in guinea‐pig small intestine
Pertwee, R. G., Fernando, S. R., Nash, J. E., & Coutts, A. A. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15663.x · Cited by 164
Self-citationOvereating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice
Poncelet, M., Maruani, J., Calassi, R., & Soubrié, P. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00397-5 · Cited by 161
Hurst, D. P., Lynch, D. L., Barnett-Norris, J., Hyatt, S. M., Seltzman, H. H., Zhong, M., Song, Z.-H., Nie, J., Lewis, D., & Reggio, P. H. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1274 · Cited by 160
McAllister, S. D., Griffin, G., Satin, L. S., & Abood, M. E. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35147-x · Cited by 160
Pertwee, R. G., Ross, R. A., Craib, S. J., & Thomas, A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02624-9 · Cited by 156
Self-citationCannabinoid receptors and reward in the rat: a conditioned place preference study
Cheer, J. F., Kendall, D. A., & Marsden, C. A. (2000) · Psychopharmacology · doi:10.1007/s002130000481 · Cited by 151
Vásquez, C., & Lewis, D. L. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09271.1999 · Cited by 150
Schlicker, E., Timm, J., Zentner, J., & Göthert, M. (1997) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005093 · Cited by 147
Darmani, N. N. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00197-4 · Cited by 145
Coutts, A. A., & Pertwee, R. G. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701301 · Cited by 145
Self-citationGessa, G. L., Casu, M. A., Carta, G., & Mascia, M. S. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00486-5 · Cited by 142
Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding
Freedland, C. S., Poston, J. S., & Porrino, L. J. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00359-2 · Cited by 141
An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice
Izzo, A. A., Capasso, F., Costagliola, A., Bisogno, T., Marsicano, G., Ligresti, A., Matias, I., Capasso, R., Pinto, L., Borrelli, F., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00892-8 · Cited by 132
Critical role of the endogenous cannabinoid system in mouse pup suckling and growth
Fride, E., Ginzburg, Y., Breuer, A., Bisogno, T., Marzo, V. D., & Mechoulam, R. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00953-0 · Cited by 129
Evidence for the presence of cannabinoid CB1receptors in mouse urinary bladder
Pertwee, R. G., & Fernando, S. R. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15643.x · Cited by 124
Self-citationKearn, C. S., Greenberg, M. J., DiCamelli, R. F., Kurzawa, K., & Hillard, C. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722379.x · Cited by 122
Substrate Specificity and Stereoselectivity of Rat Brain Microsomal Anandamide Amidohydrolase
Lang, W., Qin, C., Lin, S., Khanolkar, A. D., Goutopoulos, A., Fan, P., Abouzid, K. A. M., Meng, Z., Biegel, D., & Makriyannis, A. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980461j · Cited by 116
The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats
Izzo, A. A., Mascolo, N., Pinto, L., Capasso, R., & Capasso, F. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00673-1 · Cited by 115
Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A
Gessa, G. L., Mascia, M. S., Casu, M. A., & Carta, G. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)89683-5 · Cited by 112
Savinainen, J. R., Saario, S. M., Niemi, R., Järvinen, T., & Laitinen, J. T. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705577 · Cited by 112
Izzo, A. A., Mascolo, N., Borrelli, F., & Capasso, F. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701964 · Cited by 107
Mang, C. F., Erbelding, D., & Kilbinger, H. J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704220 · Cited by 104
The endocannabinoid system and the molecular basis of paralytic ileus in mice
Mascolo, N., Izzo, A. A., Ligresti, A., Costagliola, A., Pinto, L., Cascio, M. G., Maffia, P., Cecio, A., Capasso, F., & Marzo, V. D. (2002) · The FASEB Journal · doi:10.1096/fj.02-0338fje · Cited by 99
Meschler, J. P., Kraichely, D. M., Wilken, G. H., & Howlett, A. C. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00447-0 · Cited by 99
Verty, A. N. A., McGregor, I. S., & Mallet, P. E. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.10.035 · Cited by 98
Inhibitory effects of SR141716A on G-protein activation in rat brain
Sim‐Selley, L. J., Brunk, L. K., & Selley, D. E. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00784-1 · Cited by 95
Hillard, C. J., Muthian, S., & Kearn, C. S. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01253-3 · Cited by 93
Ruiu, S., Pinna, G. A., Marchese, G., Mussinu, J., Saba, P., Tambaro, S., Casti, P., Vargiu, R., & Pani, L. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049924 · Cited by 93
Kathmann, M., Bauer, U. S., Schlicker, E., et al. (1999) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005377 · Cited by 89
Nie, J., & Lewis, D. L. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-22-08758.2001 · Cited by 88
Cannabinoid receptor-mediated inhibition of dopamine release in the retina
Schlicker, E., Timm, J., & G�thert, M. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00166907 · Cited by 87
Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract
Casu, M. A., Porcella, A., Ruiu, S., Saba, P., Marchese, G., Carai, M. A. M., Reali, R., Gessa, G. L., & Pani, L. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02830-3 · Cited by 87
Izzo, A. A., Mascolo, N., Borrelli, F., & Capasso, F. (1999) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005325 · Cited by 81
Mato, S., Pazos, Á., & Valdizán, E. M. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01575-3 · Cited by 80
Cannabinoid modulation of intestinal propulsion in mice
Colombo, G., Agabio, R., Lobina, C., et al. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01555-0 · Cited by 78
Gifford, A. N., Bruneus, M., Gatley, S. J., & Volkow, N. D. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703599 · Cited by 77
6ʺ-Azidohex-2ʺ-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist
Thomas, A., Ross, R. A., Saha, B., Mahadevan, A., Razdan, R. K., & Pertwee, R. G. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.01.023 · Cited by 76
Self-citationVry, J. D., Schreiber, R., Eckel, G., & Jentzsch, K. R. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.10.012 · Cited by 73
White, R., & Hiley, C. R. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702127 · Cited by 70
Gifford, A. N., Tang, Y., Gatley, S. J., Volkow, N. D., Lan, R., & Makriyannis, A. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00851-3 · Cited by 69
Pinto, L., Capasso, R., Carlo, G. D., & Izzo, A. A. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0345 · Cited by 68
Modulation of peristalsis by cannabinoid CB1 ligands in the isolated guinea‐pig ileum
Izzo, A. A., Mascolo, N., Tonini, M., & Capasso, F. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703116 · Cited by 63
Ross, R. A., Gibson, T. M., Stevenson, L., Saha, B., Crocker, P. J., Razdan, R. K., & Pertwee, R. G. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702836 · Cited by 58
Self-citationCosenza, M., Gifford, A. N., Gatley, S. J., Pyatt, B. E., Liu, Q., Makriyannis, A., & Volkow, N. D. (2000) · Synapse · doi:10.1002/1098-2396(20001215)38:4<477::aid-syn13>3.0.co;2-y · Cited by 56
SR-141716A-induced stimulation of locomotor activity
Bass, C. E., Griffin, G., Grier, M. C., Mahadevan, A., Razdan, R. K., & Martin, B. R. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00945-0 · Cited by 53
Comparison of novel cannabinoid partial agonists and SR141716A in the guinea‐pig small intestine
Coutts, A. A., Brewster, N., Ingram, T., et al. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703094 · Cited by 51
Kathmann, M., Weber, B., & Schlicker, E. (2001) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000304 · Cited by 50
Rubino, T., Vigan�, D., Zagato, E., Sala, M., & Parolaro, D. (2000) · Synapse · Cited by 50
Breivogel, C. S., Walker, J. M., Huang, S. M., Roy, M. B., & Childers, S. R. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.02.017 · Cited by 49
Comparison of cannabinoid binding sites in guinea‐pig forebrain and small intestine
Ross, R. A., Brockie, H. C., Fernando, S. R., Saha, B., Razdan, R. K., & Pertwee, R. G. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702204 · Cited by 49
Self-citationTersigni, T. J., & Rosenberg, H. C. (1996) · Brain Research · doi:10.1016/0006-8993(96)00533-1 · Cited by 47
Pertwee, R. G., Fernando, S. R., Griffin, G., Ryan, W. J., Razdan, R. K., Compton, D. M., & Martin, B. R. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00631-0 · Cited by 46
Self-citationInhibition of peristaltic activity by cannabinoids in the isolated distal colon of mouse
Mancinelli, R., Fabrizi, A., Monaco, S. D., Azzena, G. B., Vargiu, R., Colombo, G., & Gessa, G. L. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01110-9 · Cited by 43
Pharmacological analysis of cannabinoid receptor activity in the rat vas deferens
Christopoulos, A., Coles, P. G., Lay, L., Lew, M. J., & Angus, J. A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703930 · Cited by 41
Modulation of the release of endogenous γ-aminobutyric acid by cannabinoids in the guinea pig ileum
Begg, M., Molleman, A., & Parsons, M. E. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01530-8 · Cited by 26
Carai, M. A. M., Colombo, G., & Gessa, G. L. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.05.005 · Cited by 24
SR141716A induces in rats a behavioral pattern opposite to that of CB1 receptor agonists.
Costa, B., & Colleoni, M. (1999) · PubMed · Cited by 23
Liao, C., Zheng, J., David, L. S., & Nicholson, R. A. (2004) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2004.pto940204.x · Cited by 20
Cited by
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Pertwee, R. G., Howlett, A. C., Abood, M. E., Alexander, S. P. H., Di Marzo, V., Elphick, M. R., Greasley, P. J., Hansen, H. S., Kunos, G., Mackie, K., et al. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003004 · Cited by 1,605
Self-citationThe endocannabinoid system and the brain.
Mechoulam, R., & Parker, L. A. (2013) · Annual Review of Psychology · doi:10.1146/annurev-psych-113011-143739 · Cited by 1,090
Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor
Laprairie, R. B., Bagher, A. M., Kelly, M. E. M., & Denovan‐Wright, E. M. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13250 · Cited by 1,039
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
Pagotto, U., Marsicano, G., Cota, D., Lutz, B., & Pasquali, R. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0009 · Cited by 865
Metadata
- Authors
- Pertwee, R. G.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2005-02
- Volume
- 76
- Issue
- 12
- Pages
- 1307-1324
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W1991132716
- Cited by
- 444
- References
- 102
- FWCI
- 18.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.